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Background: Werner Syndrome (WS) is a rare disorder characterized by the premature onset of a number of
age-related diseases. The gene responsible for WS encodes a DNA helicase/exonuclease protein believed to affect
different aspects of transcription, replication, and DNA repair. Caenorhabditis elegans (C. elegans) with a nonfunctional
wrn-1 DNA helicase ortholog also exhibits a shorter life span, which can be rescued by vitamin C. In this study, we
analyzed the impact of a mutation in the wrn-1 gene and the dietary supplementation of vitamin C on the global
mRNA expression of the whole C. elegans by the RNA-seq technology.
Results: Vitamin C increased the mean life span of the wrn-1(gk99) mutant and the N2 wild type strains at 25°C.
However, the alteration of gene expression by vitamin C is different between wrn-1(gk99) and wild type strains. We
observed alteration in the expression of 1522 genes in wrn-1(gk99) worms compared to wild type animals. Such genes
significantly affected the metabolism of lipid, cellular ketone, organic acid, and carboxylic acids. Vitamin C, in return,
altered the expression of genes in wrn-1(gk99) worms involved in locomotion and anatomical structure development.
Proteolysis was the only biological process significantly affected by vitamin C in wild type worms.
Conclusions: Expression profiling of wrn-1(gk99) worms revealed a very different response to the addition of vitamin C
compared to wild type worms. Finally, vitamin C extended the life span of wrn-1(gk99) animals by altering biological
processes involved mainly in locomotion and anatomical structure development.Background
WS is a human autosomal recessive disorder character-
ized by genomic instability and the premature onset of a
number of age-related diseases [1-4]. The defective en-
zyme responsible for WS possesses a 3′-5′ exonuclease
activity in addition to a 3′-5′ helicase activity [5,6] and
is involved in DNA repair, replication, transcription, and
telomere maintenance [7-11]. We previously generated a
mouse model with a deletion in the helicase domain of
the murine WRN homologue [12] that recapitulates
most of the WS phenotypes, including an abnormal hya-
luronic acid excretion, higher reactive oxygen species
(ROS) levels, dyslipidemia, increased genomic instability,* Correspondence: michel.lebel@crhdq.ulaval.ca
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unless otherwise stated.and cancer incidence [13,14]. Overall, such mutant mice
have a 10-15% decreased of their mean life span [15,16].
Interestingly, the treatment of Wrn mutant mice with
vitamin C reverted the life span of such animals to the
normal wild type phenotype [16].
The WRN protein is a member of the RecQ family of
DNA helicases [3]. It is highly conserved across species in-
cluding in invertebrates such as the small worm Caenor-
habditis elegans (C. elegans). Interestingly, the exonuclease
and the DNA helicase domains homologous to the human
WRN protein are encoded by two different genes in C. ele-
gans [17]. The C. elegans wrn-1 gene codes for the ATP-
dependent 3′-5′ DNA helicase capable of unwinding a
variety of DNA structures [18]. Notably, it has been
shown that the RNAi knockdown of the C. elegans wrn-
1 gene shortens the life span, increases sensitivity to
DNA damage, and accelerates aging phenotypes [17].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Impact of vitamin C on the life span of wild type and
wrn-1 mutant C. elegans strains. The difference in longevity
between vitamin C treated wrn-1(gk99) and untreated wrn-1(gk99)
C. elegans strain grown at 25°C is significant (log rank test; P =1.83 ×
10−6). The difference in longevity between vitamin C treated wild
type (N2) and untreated wild type (N2) C. elegans strain grown at
25°C is significant (log rank test; P =2.07 × 10−5). All experiments were
performed four to six times with 20 to 30 worms per genotype.
P-values were obtained using the log-rank test method.
Table 1 C. elegans genotypes used in this study




N2-1 + vitC 19,647,258
N2-2 + vitC 19,580,669




wrn-1-1 + vitC 29,673,436
wrn-1-2 + vitC 15,031,408
wrn-1-3 + vitC 25,050,297
vitC =10 mM of vitamin C (ascorbate) in media.
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wrn-1 helicase protein (wrn-1(gk99)) also exhibit a shorter
life span when grown at 25°C [19]. Interestingly, supple-
mentation of vitamin C normalizes the median life span of
the wrn-1(gk99) mutant worms [19] as seen in mice lack-
ing part of the helicase domain of the Wrn protein [16].
Thus, the wrn-1(gk99) mutant worm model gives us the
opportunity to examine the global mRNA expression of a
whole animal upon vitamin C treatment.
In this study, we analyzed the global mRNA expression
of wild type and wrn-1(gk99) mutant C. elegans in the
presence or absence of vitamin C by RNA-seq. RNA-seq
has been shown to be quantitatively accurate over a lar-
ger range of expression levels than previous methods,
such as microarrays [20-24]. Our results indicate that
wrn-1 mutant animals showed significant changes in
biological processes affecting several carbon structures
(including lipid metabolisms) and oxidation-reduction reac-
tions. Although supplementation of vitamin C significantly
increased the life span of both wild type and wrn-1 mutant
worms, no gene was similarly affected by vitamin C in these
strains. Vitamin C altered the expression of genes in wrn-1
(gk99) worms involved in locomotion and anatomical struc-
ture development. Proteolysis was the only biological
process significantly affected by vitamin C in wild type
worms. These results indicate that the expression profiling
of wrn-1(gk99) worms revealed a very different response to
the addition of vitamin C compared to wild type worms.
Results
Vitamin C increases the life span of both wrn-1(gk99) and
wild type C. elegans strains
To assess the impact of vitamin C on longevity, we mea-
sured the life span of wrn-1(gk99) and wild type C. elegans
strains grown at 25°C in the absence or presence of
10 mM ascorbate (vitamin C) as described before [19,25].
As shown in Figure 1, the median life span of vitamin C
treated wrn-1(gk99) worms was significantly increased by
26% (7.0 days versus 8.8 days) compared to untreated wrn-
1(gk99) animals (log-rank test: P =1.83 × 10−6). These re-
sults replicate previous data obtained with these strains
[19]. Interestingly, the median life span of vitamin C
treated wrn-1(gk99) worms was close to the median life
span of wild type worms (Figure 1). The median life span
of vitamin C treated wild type worms was significantly in-
creased by 22% (9.0 days versus 11.0 days) compared to
the untreated wild type animals (log-rank test: P =2.07 ×
10−5). These results indicate that vitamin C increased the
life span of both strains by more than 20% at 25°C.
Transcriptome characterization of the wrn-1(gk99) animals
compared to the wild type strain
To gain insight into the rescuing effect of vitamin C on
the life span of wrn-1(gk99) worms, we first establishedthe global expression profile of untreated wild type and
mutant worms at the L4 stage by RNA-seq. By carefully
monitored physiological developmental cues (such as
vulva and gonad development), we noticed a three hours
developmental delay in wrn-1(gk99) mutants compared
to wild type animals. Therefore, mRNA was extracted
based on the biological age (i.e. the exact developmental
stage) and not on the chronological age of the animals
for the RNA-seq analyses. Table 1 contains the number
of raw reads for each biological replicate (including the
vitamin C-treated worms). The normalized counts for
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1: Table S1 for all the C. elegans genes. A preliminary list
of differentially expressed genes was generated by keep-
ing the genes that showed a two-fold difference or more
between wild type N2 and wrn-1(gk99) worms with an
adjusted P-value <0.01. This first list contained 2528
genes (data not shown). We randomly chose 16 genes
representing a range of base mean number from 4 to
3500 reads in both or in either N2 or wrn-1 mutant ani-
mals based on the RNA-seq normalized data (list of
genes in Table 2) to determine the minimum of reads re-
quired for a gene to be detected by RT-PCR in our ana-
lyses. We thus designed 16 pairs of primers to validate
the differential expression of these genes by quantitative
RT-PCR. The tubulin encoding gene (tba-1) was in-
cluded as a control (no difference in tba-1 expression
between both strains). PolyA + RNA was thus extracted
from three plates of wild type and from three plates of
wrn-1(gk99) worms (each plate representing one bio-
logical replicate of worms at the L4 stage). The RT-PCR
results are shown in Table 2 and the sequences of the
primers are provided in the Additional file 2: Table S2.
Every RT-PCR product was examined on a 2% agarose
gel at the end of each run. Figure 2 shows examples of
such gels for ten of these genes. A PCR product was de-
tected only in samples that showed more than 145 reads
by RNA-seq (Additional file 1: Table S1). For example,
no band corresponding to nlp-32 mRNA could beTable 2 Quantitative RT-PCR compared to RNA-seq data for 1
RNA-seq


















aRT-PCRs were performed in triplicate and all values represent the means.
bThe tba-1 gene was used as a control (no difference of expression between N2 andetected with the mRNA samples and no Ct could be
detected by quantitative RT-PCR. The mean number of
reads is below 134 for nlp-32 mRNA in both the wild
type and the wrn-1(gk99) worms (Table 2). Similarly, no
arrd-24 mRNA could be detected from wild type or
wrn-1(gk99) worms mRNA pools even after 40 cycles of
PCR (Figure 2). The normalized counts for the arrd-24
gene were below 32 in both genotypes for all biological
replicates (Table 2). No Ct could be detected by quanti-
tative RT-PCR. In contrast, a band for the ugt-33 gene
was detected with mRNA from the wild type worms
only (no band was detected for the wrn-1(gk99) worms)
(Figure 2). The mean number of reads was lower than
145 for ugt-33 in the wrn-1(gk99) worms but higher than
145 in the wild type worms (Table 2). Finally, Table 2 in-
dicated expression differences for pes-8, cyp-34a9, cyp-
33e2, sodh-1, ugt-33, ech-9, nas-3, gpx-3, acs-2, acs-14,
asah-1, lys-8, Y46G5.20, and daf-9 genes between the
wild type and the wrn-1(gk99) strains by RT-PCR ana-
lyses and such results confirmed the RNA-seq data. A
mean number of reads greater than 145 was found in at
least one of the genotypes following the RNA-seq ana-
lysis for these genes (Table 2). Based on such results, we
generated a final list of genes showing at least a two-fold
difference in expression between wild type and mutant
worms, an adjusted P-value <0.01, and a mean number
of reads >145 in at least one of the worm strain. These
criteria were applied to each comparison hereafter in6 genesa
RT-PCR
Fold difference ΔCt Fold difference P-value
+10.79 3.02 +8.09 <0.001
+7.80 none N/A N/A
+6.21 1.07 +3.24 0.0012
+4.51 1.78 +3.43 <0.001
+3.60 1.48 +2.78 <0.001
+3.06 0.72 +1.65 0.0008
+3.30 1.80 +3.48 <0.001
+3.00 0.52 +1.43 0.0307
+2.89 1.94 +3.84 0.0006
−3.10 −2.05 −4.14 0.0001
−3.12 −2.70 −6.52 <0.001
−3.41 −2.05 −4.15 <0.001
−3.84 −2.06 −4.16 0.0204
−3.90 −1.67 −3.18 0.0008
−21.93 −4.45 −21.87 <0.001
−28.69 none N/A N\A
−1.19 −0.12 −1.09 0.7083
d wrn-1 mutants).
Figure 2 Examples of RT-PCR products on 2% agarose gel.
Results are shown for nlp-32, pes-8, cyp34a9, cyp-33e2, sodh-1, acs-2,
ugt-33, acs-14, nas-3, and arrd-24 genes after 40 cycles of PCR.
M = marker in base pairs; N2 = wild type strain; wrn-1 = wrn-1(gk99)
C. elegans strain.
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1522 genes differentially expressed between wild type
and wrn-1(gk99) worms. There were 907 down regulated
and 615 up regulated genes respectively (by at least two-
fold) in the wrn-1(gk99) worms compared to the wild
type worms.
The DAVID classification tool was used to classify dif-
ferentially expressed genes by their functions in specific
biological processes. Categorization of the genes in our
list (Additional file 3: Table S3) revealed ten significantly
up regulated biological processes (with a Benjamini P-
value <0.05) in the wrn-1(gk99) worms compared to wild
type worms (Table 3). Major biological processes that wereTable 3 Biological processes altered in wrn-1(gk99) C. elegans




Organic acid metabolic process 1.34E-04 R09B5.6, F08A8.3, F56H
C44E4.3, C05E4.9, T21F
F59B8.2, ZC416.6, ZK12
Cellular ketone metabolic process 1.78E-04 R09B5.6, F08A8.3, F56H
C44E4.3, C05E4.9, T21F
F59B8.2, ZC416.6, ZK12








Carbohydrate metabolic process 0.0147 R09B5.6, C05E4.9, Y22F
H23N18.1, Y37E11AR.5,
D2096.3, H22K11.2, H02up regulated in wrn-1(gk99) worms included oxidation-
reduction processes, lipid, organic acid, cellular ketone,
and carbohydrate metabolic processes (Table 3). There
was no significant down regulated biological processes
(with a Benjamini P-value <0.05).
Transcriptome characterization of wrn-1(gk99) and wild
type strains treated with vitamin C
We compared the global mRNA expression of synchro-
nized untreated worms with synchronized worms grown
with vitamin C until the L4 stage. Lists of genes differen-
tially expressed were generated by requiring that the ab-
solute value of the fold change be higher than two, that
the mean number of reads for each gene be higher than
145 for at least one of the genotype, and the adjusted P-
value be lower than 0.01. When we compared the global
expression of untreated wrn-1(gk99) worms with vitamin
C treated wrn-1(gk99) worms, we found 311 genes to be
differentially expressed (139 down and 172 up regulated
genes, respectively) between both populations (Additional
file 4: Table S4). DAVID analysis on this list of genes re-
vealed enrichments for two main down regulated bio-
logical processes (Table 4). The main affected processes
included genes involved in locomotion and anatomical
structure development. No significant biological processes
were up regulated (with a Benjamini P-value <0.05). When
we compared the global expression of untreated wild type
worms with vitamin C treated wild type worms, we found
296 genes to be differentially expressed (193 down and
103 up regulated genes, respectively) between both popu-
lations (Additional file 5: Table S5). DAVID analysis on
this list of genes revealed a significant down regulation of
only one set of genes involved in proteolysis (Table 4).strain compared to the wild type N2 strain
11.4, F08A8.1, C12C8.2, F08A8.2, F28F8.2, M02D8.4, W08D2.4, C48B4.1,
4.1, T09B4.8, F01G10.3, K07E1.1, Y73F4A.2, F21F8.4, D1025.2, W09B6.1,
90.12, F13D12.4, K10H10.2, ZK829.4, R08E5.2, R11A5.4
11.4, F08A8.1, C12C8.2, F08A8.2, F28F8.2, M02D8.4, W08D2.4, C48B4.1,
4.1, T09B4.8, F01G10.3, K07E1.1, Y73F4A.2, F21F8.4, D1025.2, W09B6.1,
90.12, F13D12.4, K10H10.2, ZK829.4, R08E5.2, R11A5.4
8.1, F56H11.4, F28F8.2, F08A8.2, K11D2.2, W08D2.4, Y52B11A.8, F09C8.1,
.9, T05E7.1, F59F4.4, F46G10.4, F01G10.3, C40H1.7, H23N18.1, Y37E11AR.5,
2A.45, F22E10.5, F21F8.4, F35C11.5, T19H12.10, W09B6.1, F28H7.3, ZC416.6,
3C12.3, F54D11.1, W04C9.1
3C5.1, F08A8.2, C47A10.5, T08B1.3, F54D8.3, C48B4.1, K08C7.5, R02D3.1,
11.1, C11E4.2, R07B7.5, K06A4.5, F08F3.7, F36A2.3, R11D1.11, R04B5.5,
3.1, F13D12.4, ZK829.4, K12G11.3, K09D9.2, C30G12.2, Y5H2B.5,
5A.4, Y22F5A.5, T19H12.9, F07A11.2, F07A11.5, R11F4.1, C02A12.4,
T12B3.3, Y73F4A.2, ZK678.8, F01F1.12, R11D1.11, R05F9.6, T19H12.10,
I12.1, C05C8.7, R09D1.10, Y46G5A.31, C33C12.3, R11A5.4
Table 4 Comparison of biological processes altered in wrn-1 mutant or wild type C. elegans strains treated with
vitamin C
Down in wrn-1 mutant + vitamin C vs untreated wrn-1 mutant C. elegans strain
Category Benjamini P-value Genes
Locomotion 0.0081 K07D8.1, C29F4.1, W05B2.1, T10E10.2, T28C6.6, T10E10.6, F46B3.5, F38A3.2, F55C10.3,
T01B10.2, T28C6.4, C44C10.1, T22A3.8, F13H6.1, C26C6.3, F30B5.1, ZK270.1, Y4C6B.2,
ZK678.5, W05B2.6, T07H6.3, K07C10.1, W05B2.5, Y41E3.2
Anatomical structure development 0.0065 C29F4.1, T10E10.2, T10E10.6, C29E4.1, C09G5.4, F38A3.2, T01B10.2, C44C10.1,
F37B4.2, T07H6.3, F52B11.4, W05B2.1, T22B3.1, F27C1.8, T28C6.6, F55C10.3,
T28C6.4, T22A3.8, F30B5.1, F11G11.10, B0491.2, F11G11.12, ZK270.1, W05B2.6,
Y41E3.2, W05B2.5
Up in wrn-1 mutant + vitamin C vs untreated wrn-1 mutant C. elegans strain
No significant category
Down in N2 + vitamin C vs untreated N2 C. elegans strain
Category Benjamini P-value Genes
Proteolysis 0.0408 T23F4.4, ZK1037.10, F53A9.2, K07B1.1, W07B8.4, T19D2.1, W01A8.6,
C29F3.2, B0222.4, F47H4.10, F42A10.8, Y95B8A.1, R10H1.5, C07D10.4
Up in N2 + vitamin C vs untreated N2 C. elegans strain
No significant category
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versus untreated wild type worms was very different from
the list of differentially expressed genes in untreated wrn-1
(gk99) versus vitamin C treated wrn-1(gk99) worms.
Only four genes were regulated in a similar way in both
lists and they included mup-4, C27D9.2 (down regu-
lated), F12A10.1, and ugt-18 (up regulated). The mup-4
gene encodes a transmembrane protein required for
junctional attachments between hypodermis and muscle
[26]. The ugt-18 gene encodes a protein with putative
UDP- glucuronosyltransferase activities (referenced in
www.ncbi.nlm.nih.gov/gene/179759). The C27D9.2 and
F12A10.1 genes code for uncharacterized proteins (www.
wormbase.org). These results indicate that although vita-
min C increased the life span of both mutant and wild
type worms, it affected different sets of genes and bio-
logical processes in both strains.
The life span of wrn-1(gk99) worms treated with vitamin
C is similar to the life span of untreated wild type worms
(Figure 1). We therefore compared the global expression
of vitamin C treated wrn-1(gk99) worms with the global
expression of untreated wild type worms. There were 375
down regulated and 181 up regulated genes in the vitamin
C treated wrn-1(gk99) worms compared to untreated wild
type worms, respectively (Additional file 6: Table S6).
Categorization of the genes in our list using DAVID re-
vealed three significantly up regulated biological processes
(Benjamini P-value <0.05) in the vitamin C treated wrn-1
(gk99) worms compared to untreated wild type worms
(Table 5). Major biological processes that were up regu-
lated in vitamin C wrn-1(gk99) mutant worms included
lipid, cellular ketone, and organic acid metabolic processes
(Table 5).We next examined the genes that were commonly altered
in untreated and vitamin C treated wrn-1(gk99) worms tak-
ing the global expression of the wild type strain as a refer-
ence. The Venn diagrams in Figure 3 indicate on one hand
that the expression of 472 genes from the wrn-1(gk99)
worms were changed similarly in the absence or presence
of vitamin C when compared to wild type worms. There
were 317 and 155 genes down and up regulated, respect-
ively, in the wrn-1(gk99) worms with or without vitamin C
compared to untreated wild type worms. The list of these
genes can be found in (Additional file 7: Table S7). DAVID
analyses on the commonly up and down regulated genes
indicated that the wrn-1(gk99) mutation increased the ex-
pression of genes involved in oxidation-reduction, cellular
ketone, organic acid, and lipid metabolic processes (Table 6).
These results indicate that vitamin C did not revert the ex-
pression of genes involved in these biological processes in
the wrn-1(gk99) worms.
Potential transcription factors involved in vitamin
C response in wrn-1(gk99) and wild type C. elegans
We next performed a transcription factors binding site en-
richment analysis on the promoters of the genes altered by
vitamin C in both wrn-1(gk99) and wild type strains. We
used publically available ChIP-seq data recently generated
for 164 transcription factors in C. elegans [27]. Promoter
analysis of all the genes differentially expressed by vitamin
C in wild type worms revealed a significant enrichment of
binding sites for NHR-28 and MAB-5 transcription factors
(see the Additional file 8: Table S8). The C. elegans NHR-28
protein is an orphan nuclear hormone receptor with zinc
finger domains required for DNA binding (www.worm-
base.org). MAB-5 is a homeodomain transcription factor
Table 5 Biological processes altered in vitamin C treated wrn-1 mutant compared to the untreated wild type
C. elegans strain
Up in wrn-1 mutant + vitamin C vs untreated N2 C. elegans strain
Category Benjamini P-value Genes
Lipid metabolic process 0.0014 R09B5.6, F35C11.5, F08A8.2, F01D4.2, K11D2.2, F09C8.1, C48B4.1,
ZC416.6, Y49E10.18, ZC443.5, T05E7.1, F46G10.4, F01G10.3, C40H1.7
Cellular ketone metabolic process 0.0039 C44E4.3, R09B5.6, ZK829.4, Y73F4A.2, T21F4.1, F08A8.2, R08E5.2,
M02D8.4, F01G10.3, C48B4.1, ZC416.6
Organic acid metabolic process 0.0043 C44E4.3, R09B5.6, ZK829.4, Y73F4A.2, T21F4.1, F08A8.2,
R08E5.2, M02D8.4, F01G10.3, C48B4.1, ZC416.6
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homeodomain proteins. It regulates proliferation, differen-
tiation and morphogenesis in C. elegans [28]. The expres-
sion of nhr-28 and mab-5 genes was not significantly
changed in vitamin C treated compared to untreated wild
type animals (Additional file 1: Table S1). These results
suggest that vitamin C altered the activity of these tran-
scription factors at a post-transcriptional level in wild type
animals.
Promoter analysis of all the genes differentially expressed
by vitamin C in wrn-1(gk99) mutant worms revealed a
significant enrichment of binding sites for TLP-1, NHR-
76, PHA-4 and NHR-28 transcription factors (see the
Additional file 9: Table S9). TLP-1 is a zinc finger protein
of the Sp family of transcription factor. It is a transcription
factor that acts downstream of Wnt signals and that con-
trol cell polarity and patterning in C. elegans [29]. NHR-76Figure 3 Venn diagrams showing the number of genes similarly alter
of vitamin C compared to untreated wild type worms. The number ofis a nuclear hormone receptor transcription factor in-
volved in body fat regulation in C. elegans [30]. PHA-4 is a
transcription factor of the FoxA (forkhead) family that me-
diates diet-restriction induced longevity in C. elegans [31].
It also antagonizes the Target of Rapamycin pathway in
C. elegans [32]. The expression level of these four tran-
scription factors in wrn-1(gk99) mutant worms was not
significantly changed by the addition of vitamin C
(Additional file 1: Table S1). These results suggest that vita-
min C altered the activity of these transcription factors at a
post-transcriptional level in wrn-1(gk99) mutant worms.
Discussion
We have previously observed that homozygous mice lack-
ing exons encoding part of the helicase domain of the
Werner syndrome gene product have a reduced mean
life span of 16.5% compared to wild type mouse [16].ed in wrn-1 mutant C. elegans strains in the presence or absence
genes commonly down regulated or up regulated is also indicated.
Table 6 Biological processes commonly altered in the wrn-1 mutant C. elegans strain in the presence or absence of
vitamin C
Up in wrn-1 mutant+/−vitamin C vs untreated N2 C. elegans strain
Category Benjamini P-value Genes
Cellular ketone metabolic process 0.0015 C44E4.3, R09B5.6, ZK829.4, Y73F4A.2, T21F4.1, F08A8.2, R08E5.2,
M02D8.4, F01G10.3, C48B4.1, ZC416.6
Organic acid metabolic process 0.0022 C44E4.3, R09B5.6, ZK829.4, Y73F4A.2, T21F4.1, F08A8.2, R08E5.2, M02D8.4,
F01G10.3, C48B4.1, ZC416.6
Lipid metabolic process 0.0028 Y49E10.18, R09B5.6, F35C11.5, F08A8.2, K11D2.2, T05E7.1, F46G10.4,
F01G10.3, C48B4.1, F09C8.1, C40H1.7, ZC416.6
Oxidation-reduction 0.0391 K08C7.5, R07B7.5, R02D3.1, ZK829.4, K12G11.3, C30G12.2,
K09D9.2, T13C5.1, F08A8.2, R04B5.5, C48B4.1
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high oxidative stress that can be neutralized by supple-
mentation of vitamin C in drinking water [16]. In fact,
vitamin C re-established the normal mean life span of
Wrn helicase mutant mice. Interestingly, C. elegans
lacking the wrn-1 helicase ortholog also have a reduced
mean life span compared to wild type worms [19]. The
global mRNA expression of whole wrn-1(gk99) worms
by RNA-seq analyses indicated major changes in set of
genes involved in overall carbon metabolism (sugars
and lipids). These results are consistent with the prema-
ture aging phenotype observed in worms with a reduced
WRN-1 helicase activity [19,33]. Although the analysis
was performed on mRNA from L4 stage C. elegans, al-
tered expression of these genes will have an effect on
the duration of adulthood. Indeed, alterations in react-
ive oxygen species and ATP levels has been observed in
adult wrn-1(gk99) mutant worms [19]. Notably, alter-
ation in the expression of several sets of genes involved
in growth and lipid or fatty acid metabolism has not
only been observed in cultured Wrn mutant mouse em-
bryonic fibroblasts but also in the liver of Wrn helicase
mutant mice [16,34]. Importantly, since we noticed a
three hours developmental delay in wrn-1(gk99) animals
compared to wild type, we carefully monitored physio-
logical developmental cues (i.e. vulva and gonad devel-
opment) in both animal population before harvesting
them to perform mRNA analysis (as described in the
Methods). Therefore, the change of the expression pro-
file of genes involved in different biochemical pathways
observed between wrn-1(gk99) mutant and wild type
animals reflect accurately the difference detected at a
specific developmental time point rather than a devel-
opmental shift caused by the loss of wrn-1. Detailed
comparative microscopic and genetic analyses along
with global mRNA expression analyses at several de-
velopmental stages will be necessary to acquire a bet-
ter picture of changes as a function of not only
chronological but also biological age in wrn-1(gk99)
mutant animals.Vitamin C treatment increased the mean life span of
wrn-1(gk99) worms to untreated wild type levels. This is
similar to the result obtained with mice. Vitamin C sup-
plementation rescued the shorter mean life span of Wrn
mutant mice [16]. Vitamin C also significantly increased
the life span of wild type C. elegans (Figure 1). We did not
see an increase in the life span of wild type mice supple-
mented with vitamin C in a previous study [16]. Unlike
mice, wild type C. elegans do not have the enzyme re-
quired for the synthesis of their own vitamin C as far as
we can tell. However, C. elegans contains three potential
cytochromes b561 encoding genes (F55H2.5, F39G3.4 and
F39G3.5) [35]. Cytochromes b561 are intrinsic membrane
proteins containing two heme molecules, and reducible by
ascorbate. They have been suggested to function as elec-
tron transporters, shuttling electrons across membranes
from ascorbate to an acceptor molecule. The one-electron
oxidation product of ascorbate, monodehydro-ascorbate
has been shown, at least in vitro, to function as an electron
acceptor for cytochromes b561. This reaction results in
the regeneration of a fully reduced ascorbate molecule
[35]. The presence of Cytochromes b561 encoding genes
in C. elegans suggests that this species could potentially
use vitamin C in different chemical reactions [36]. The im-
pact of vitamin C on the levels of different metabolites re-
quired for energy or impacting on ROS levels in the body
of wild type and wrn-1(gk99) C. elegans is currently under
investigation. Interestingly, the expression of the F39G3.4
gene is reduced in wrn-1(gk99) mutants (Additional file 3:
Table S3) but was not changed by the addition of vitamin
C (Additional file 4: Table S4). The F39G3.4 gene may
be required for the regeneration of ascorbate from
monodehydro-ascorbate in wrn-1(gk99) mutants, a hy-
pothesis that will require confirmation.
Our results indicate a major difference in gene expres-
sion response to vitamin C between wild type and mutant
worms. The list of differentially expressed genes in un-
treated wrn-1(gk99) mutants versus vitamin C treated wrn-
1(gk99) mutants was very different from the list of genes
in vitamin C treated wild type versus untreated wild type
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5: Table S5). These results indicate that although vita-
min C increased the life span of both mutant and wild
type worms, it affected different sets of genes in both
strains. Another important difference is that the mean life
span of vitamin C treated wrn-1(gk99) worms is shorter
(~9 days) than vitamin C treated wild type worms (11 days)
(Figure 1). The median life span of wrn-1(gk99) worms
treated with vitamin C was close to untreated wild type
worms. The expression profile of vitamin C treated wrn-1
(gk99) worms compared to untreated wrn-1(gk99)
worms revealed down regulation of genes involved in
biological processes related to locomotion and anatom-
ical structure development. Upon examination of the
global mRNA expression analysis of treated and un-
treated wrn-1(gk99) worms (taking the global mRNA
expression of wild type as a reference), we found that
the expression of 472 genes at the mRNA level was
similarly altered in mutant worms compared to wild
type worms in the presence or absence of vitamin C.
The expression of these genes was affected by the wrn-1
(gk99) mutation but was not reversed by vitamin C sug-
gesting that alteration in expression of these genes is not
required for the impact of vitamin C on C. elegans life
span. These genes are involved in oxidation-reduction, cel-
lular ketone, organic acid, and lipid metabolic processes
(Table 6). Thus, vitamin C extended the life span of wrn-1
(gk99) worms by altering biological processes not only in-
volved in locomotion but also in anatomical structure
development (Table 4). Such processes are indeed af-
fected at the physiological levels, as a knock down of
WRN-1 protein expression by the RNA interference
technique results in various developmental defects, in-
cluding small, dumpy, ruptured, transparent body,
growth arrest and bag of worms [33].
The mechanism by which vitamin C alters gene ex-
pression in mutant and wild type C. elegans is unknown.
Our analysis of enrichment for specific transcription factor
binding sites in the altered genes in the presence of vita-
min C have indicated changes in the activity of hormone
receptor-type transcription factors (like NHR-28 and
NHR-76) and of PHA-4, a transcription factors which ac-
tivity depends on pathways affecting the status of several
metabolites and/or nutrients in C. elegans. One important
pathway modulated by metabolites is the CeTOR pathway
that affects PHA-4 activity [32]. Our hypothesis is that
vitamin C not only affects the redox status of cell in C. ele-
gans, but also important metabolites that may be used as
ligands for nuclear receptors (lipid derived steroidogenic
metabolites) or for signaling molecules that regulate the
activity of different transcription factors. Metabolomics
analysis with both wrn-1(gk99) mutant and the N2 wild
type strains in the absence or presence of vitamin C is un-
derway and is the scope of another study.Conclusions
To conclude, our study indicates that 10 mM vitamin C
in the growth media increases the mean life span of the
wrn-1(gk99) mutant and the N2 wild type strains at 25°
C. However, the alteration of gene expression by vitamin
C is different between wrn-1(gk99) and wild type strains.
Based on our criteria to generate lists of differentially
expressed genes between genotypes, we observed alter-
ation in the expression of 1522 genes in wrn-1(gk99)
worms compared to wild type worms. Vitamin C did not
significantly modify the alteration of 472 of these genes.
Such genes are mainly involved in oxidation-reduction,
cellular ketone, organic acid, carbohydrate, and lipid,
metabolic processes. Vitamin C, in return, altered the
expression of several genes in wrn-1(gk99) worms in-
volved in locomotion and anatomical structure develop-
ment. It is interesting to mention that vitamin C can
rescue the morphology of liver and adipose tissues of
Wrn helicase mutant mice [16]. This report thus pro-
vides lists of genes that can potentially affect the healthy
aging of not only wild type but also wrn-1(gk99) worms
upon genetic manipulation in the presence of vitamin C.
It also provides important clues on the biological pro-




All C. elegans strains were maintained as described [37].
The wrn-1(gk99) strain was obtained from the C. elegans
Genetics Center (University of Minnesota, St Paul, MN)
and was out-crossed four times with the wild type N2
strain to remove possible unrelated mutations. The wrn-1
(gk99) contains a 196 bps deletion that inhibits the expres-
sion of the protein [38]. The primers used to genotype this
strain are 5′-CTGGCTGTAACTGCACCTGA-3′ and
5′-AAATGGGAGGGAAAGAGCAT-3′. To measure life
span, worms were transferred to fresh plates and were
grown at 25°C. Death was scored by absence of any move-
ment after several light pokes with a platinum wire.
Extraction of total RNA and sequencing
Eggs were isolated by standard bleach treatment and
hatched overnight at room temperature. The resulting
L1 larvae were then distributed over NGM plates sup-
plemented or not with 10 mM vitamin C (Sodium L-
ascorbate) (Sigma-Aldrich, ST-Louis, MO) and grown
at 25°C. A concentration of 10 mM ascorbate was
chosen in this study as it has previously been shown
that such a concentration did not influence the survival
of C. elegans [25]. The developmental stage of the ani-
mals was monitored visually until the worms reached
the larvae L4 stage. Animals were precisely staged by
observing vulval and gonad formation by Nomarski
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previously [39]. Worms were spun down in an eppendorf
tube and lysed in TRIZOL (Invitrogen, Carlsbad, CA) to
extract total RNA. RNA quality was checked with an Agi-
lent Bioanalyzer 2100 and libraries were made using the
Illumina’s TruSeq v2 kit according to the manufacturer’s
recommendations. The RIN (RNA Integrity Number) of
all samples was above 8.0. Fifty base pairs paired end se-
quencing was performed on the HiSeq 2000 machine
form Illumina.
RNA-seq analyses
The data discussed in this publication have been deposited
in NCBI’s Gene Expression Omnibus http://www.ncbi.nlm.
nih.gov/geo/ [40] and are accessible through GEO Series
accession number GSE54173. Table 1 contains the read sta-
tistics for the raw reads coming off the sequencer. Detailed
statistics on the quality of the reads were calculated
with FastQC (http://www.bioinformatics.babraham.ac.
uk/projects/fastqc/). The 50 base pairs raw sequences
were aligned on the C. elegans ce10/W220 genome with
TopHat [41] using the Ensembl annotations provided
with the Illumina iGenomes. The htseq-count software
(http://www-huber.embl.de/users/anders/HTSeq) was
used to count the number of reads aligned to each gene.
These counts were then normalized relative to the se-
quencing depth with DESeq [42]. DESeq was also used
to calculate the fold changes, log fold changes, and sig-
nificance of the changes for each comparison.
Enrichments for specific biological functions using the
DAVID (Database for Annotation, Visualization, and In-
tegrated Discovery) web site [43] were considered sig-
nificant with a P-value smaller than 0.05.
Validation of mRNA expression
The quantitative measure of selected mRNA expressions
was performed by qRT-PCR. Worms were spun down in
an eppendorf tube and lysed in TRIZOL (Invitrogen,
Carlsbad, CA) to extract total RNA. PolyA + RNA was iso-
lated with the RNeasy plus mini kit (Qiagen, Mississauga,
ON). The cDNAs were obtained by reverse transcrip-
tion using the specific 3′-primer on total RNA (Additional
file 2: Table S2 for primer design). cDNA were then sub-
jected to qPCR reaction using PerfeCTa® SYBR® Green
FastMix®, Low ROX™ (Quanta Bioscience, Gaithersburg,
MD) according to manufacturer instruction. At the end of
each run, samples were analyzed on a 2% agarose gel to
determine the quality of the amplification. Primers used
for qRT-PCR are listed in (Additional file 2: Table S2).
modENCODE transcription factors binding site
enrichment analysis
We downloaded a list of 164 significant ChIP-seq peaks
mapped on the ws220 C. elegans genome from themodENCODE FTP website (ftp://data.modencode.org/)
[27]. Using this significant list of peaks, we first defined for
every transcription factors a list of genes located within
500 bp of at least one significant peak. Using this list of
genes we computed the overlap enrichment scores be-
tween the list of genes targeted by the transcriptions fac-
tors and the list of significantly differentially expressed
genes identified in our wrn-1 and wild type gene expres-
sion experiments for up-regulated, down-regulated and all
significant genes. The enrichment was evaluated based on
a one-sided hypergeometric distribution. We consider an
enrichment between genes targeted by a transcription fac-
tor and the list of genes modulated by vitamin C to be sig-
nificant if the Benjamini-Hochberg adjusted p-value is
lower than 0.05.
Additional files
Additional file 1: Table S1. Normalized counts for each biological
replicate. This list gives the normalized number of reads for each gene in
each replicate.
Additional file 2: Table S2. Primers used for the quantitative RT-PCR.
Additional file 3: Table S3. List of genes found to be differentially
expressed in the wrn-1 mutant compared to the wild type N2 worms.
The columns labeled baseMeanA and baseMeanB represent the mean
number of reads (from the normalized counts of Additional file 1: Table S1)
for the N2 wild type and the wrn-1(gk99) strains, respectively.
Additional file 4: Table S4. List of genes found to be differentially
expressed in the vitamin C treated wrn-1 mutant compared to untreated
wrn-1 mutant worms. The columns labeled baseMeanA and baseMeanB
represent the mean number of reads (from the normalized counts of
Additional file 1: Table S1) for the untreated wrn-1(gk99) and the vitamin
C treated wrn-1(gk99) worms, respectively.
Additional file 5: Table S5. List of genes found to be differentially
expressed in the vitamin C treated wild type N2 compared to untreated
wild type N2 worms. The columns labeled baseMeanA and baseMeanB
represent the mean number of reads (from the normalized counts of
Additional file 1: Table S1) for the untreated N2 wild type and the
vitamin C treated N2 wild type worms, respectively.
Additional file 6: Table S6. List of genes found to be differentially
expressed in the vitamin C treated wrn-1 mutant compared to untreated
wild type worms. The columns labeled baseMeanA and baseMeanB
represent the mean number of reads (from the normalized counts of
Additional file 1: Table S1) for the untreated N2 wild type and the vitamin
C treated wrn-1(gk99) worms, respectively.
Additional file 7: Table S7. Genes differentially expressed in a similar
way in wrn-1 mutant worms incubated with or without vitamin C
compared to the untreated wild type N2 worms.
Additional file 8: Table S8. List of transcription factors potentially
binding to the promoters of genes altered by vitamin C in wild type worms.
Additional file 9: Table S9. List of transcription factors potentially
binding to the promoter of genes altered by vitamin C in wrn-1
mutant worms.
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